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1. Introduction 
Non-invasive in vivo molecular imaging using radionuclides is based on the Radiotracer 
Principle of G. von Hevesy and the magic bullet concept by Ehrlich (1990). Both principles 
require administration of a radioactive tracer (a molecule labelled with a radioactive isotope 
which when injected into a living object can be traced by external radiation detection 
devices) and require that the quantity is in sub-pharmacological amounts, i.e. that minimal 
mass is injected, which in radiopharmaceutical terms means high specific activity.  
1.1 Specific activity: The concept 
According to the more updated terminology that is going to be recommended by the IUPAC, 
the concept of specific activity (AS) is defined as the activity of a radionuclide divided by the 
mass (or molar amount) of the sum of all radioactive and stable nuclides (present in the same 
chemical and physical form) isotopic with the element involved (Bonardi, 2003). Thus, if one 
thinks of an injectable solution of, for instance, 3,5-dichloro-N-[[(2S)-1-ethylpyrrolidin-2-
yl]methyl]-2-hydroxy-6-([11C]methoxy)benzamide or [11C]Raclopride (a post-synaptic D2 
receptor antagonist which is used for the quantification of D2-like dopamine receptors (Elsinga 
et al., 2006) with different clinical applications, e.g. distinction of multiple system atrophy from 
Parkinson disease (Van Laere et al., 2010)), what one has in solution before administration to 
the patient is a mixture of different (chemically identical) species (A+B+C+D in Figure 1).  
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Fig. 1. Chemical structure of [11C]Raclopride and chemically identical species which co-
exists with the radioactive specie. All carbon atoms whose mass number is not specified are 
12C, 13C or 14C.  
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The AS of the radiotracer can thus be expressed as the ratio between the amount of 
radioactivity (given by the number of molecules containing a Carbon-11 atom, A in Figure 1) 
and the number of molecules (expressed as mass or molar quantity) containing Carbon-11 or 
other (stable and unstable) isotopes of Carbon (A+B+C+D in Figure 1). 
In the context of radiopharmaceuticals, other definitions have been described for different 
situations that occur when analyzing the final radioactive product. Thus, the term effective 
specific activity is used to describe the mass or molar quantity of a single species radiotracer 
relative to the total mass or molar quantity of the radiotracer and non-radioactive 
compound(s) that have similar biochemical properties. For instance, proteins can be labelled 
with positron emitters (e.g. 68Ga) by (covalently) attaching a bifunctional chelator to 
introduce later on the metallic radioactive atom. The chemical structure of the labelled (C in 
Figure 2) and unlabelled (B in Figure 2) species are very similar (although not identical) and 
thus it can be anticipated that both compounds will have very similar biochemical 
properties. Isolation of the labelled compound is not (usually) feasible and effective specific 
activity is defined as the ratio between the amount of radioactivity (given by the number of 
molecules containing a gallium-68 atom, C in Figure 2) and the number of molecules 
(expressed as mass or molar quantity) with similar biochemical properties (B and C in the 
Figure). This concept is mainly applied in the context of macromolecules (e.g. labelled 
proteins, antibodies, peptides, polymers), nanostructures (nanoparticles, nanotubes) and 
also when, in smaller molecules, undesired contaminants (which cannot be separated from 
the labelled structure but have similar biochemical properties) are present in the final 
solution.   
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Fig. 2. Schematic reaction pathway for the introduction of a positron emitter (68Ga in the 
example) in a macromolecule (protein). The labelled and unlabelled structures (B and C) are 
almost identical and have similar (if not identical) biochemical properties.  
When in vivo imaging studies are performed, the amount of radioactivity to be administered 
is somehow fixed within a range: It has to be sufficiently high to allow acquiring good 
quality images but low enough to prevent saturating of the radio-detectors and, eventually, 
damage to the organism due to radiation exposure. Thus, the AS will definitely determine 
the molar amount of radiotracer. In some applications such as the study of the behaviour of 
bioactive or toxic molecules, dose exposure studies and the visualization of low density 
receptors in the brain, the concept of AS becomes especially relevant, provided that the 
quantity of injected tracer can definitely produce undesired pharmacodynamic or 
toxicological effects, as well as target (e.g. receptor) saturation. In some cases, when the 
injected compound is endogenous  and normally found in µM or higher concentrations in 
the body (e.g. [15O]water, [11C]acetate,  [11C]glucose) or that the target or function is not 
saturated easily (e.g. glucose metabolism -  [18F]FDG , hypoxia - [18F]FMISO, enzyme 
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activity; thymidine kinase 1 - [18F]FLT) specific activity is  not crucial. For macromolecules it 
is known that the highest specific activity is not necessary the optimal one. This has been 
reported for peptides (de Jong et al., 1999; Bernhardt et al., 2003; Schuhmacher et al., 2005; 
Velikyan et al., 2010) and antibodies (Pandit-Taskar et al., 2008). 
Although theoretical AS values for PET isotopes are very high (e.g. 341.1 TBq/µmol for 
Carbon-11, 63.3 TBq/µmol for Fluorine-18) these values are usually very far (10-10000 times 
higher) from those values obtained once the radiotracer has been synthesized. This decrease 
in AS is due to a dilution process with the non radioactive isotope, usually occurring during 
radionuclide production and/or manipulation and preparation of the radiotracer. This fact 
is well known among the scientific community; however, the number of factors contributing 
to the introduction of stable isotopes during the production process is very high and usually 
difficult to be controlled. These potential sources of stable isotopes become relevant when 
simple calculations are performed. For instance, in 37 GBq of [11C]CO2 (a radioactive 
precursor typically used for the preparation of 11C-labelled radiotracers) the number of 
molecules (when AS is the theoretical value, 341.1 TBq/µmol ) is only 6.53x1013 (0.108 nmol). 
The introduction of (only) 1 or 100 nmol of non radioactive CO2 will decrease AS by a factor 
of 10 or 1000, respectively.  
Despite the dramatic consequences of incorporation of minute amounts of non radioactive 
carbon on AS, the number of systematic approaches for the study of contamination sources 
reported in the literature is scarce, and syntheses under (apparently) identical experimental 
conditions might lead to immense differences in AS values of the final radiotracer. These 
facts have led to perpetual discussions among scientists regarding the optimal procedures to 
be followed to improve AS, especially in the case of Carbon-11 labelled radiotracers.    
1.2 Carbon-11: A challenging isotope 
Among all radionuclides, only a few of them have the adequate physical properties to 
become suitable candidates for the preparation of radiotracers. In the particular case of 
positron emitters, there are four radionuclides which have been historically used: Carbon-
11, Nitrogen-13, Fluorine-18 and Oxygen-15. The wide historical use of these isotopes is due 
to (i) they can be produced in relatively high yields in commercially available cyclotrons, (ii) 
they can be easily introduced in biomolecules, (iii) their decay mode is close to 100% 
positron emission (see table 1) and (iv) their stable isotopes are present in all organic 
molecules; this last statement is not true in the case of fluorine, but in many cases the 
substitution of an hydroxyl group (or hydrogen atom) by a fluorine atom does not 
significantly alter the biological behaviour of the molecule; thus fluorine can be used to 
prepare analogues of molecules with specific biological characteristics. 
Among these four PET isotopes, Fluorine-18 is probably the most widely used, especially for 
clinical applications. Fluorine-18 forms strong covalent bonds with carbon atoms and can be 
incorporated into a large variety of organic molecules; on the other hand, substitution of a 
hydrogen atom by a fluorine atom causes little steric alterations in the molecule; in some 
particular cases, the biological properties of the radiotracer are even improved with respect 
to the original molecule. Moreover, Fluorine-18 has a small positron range and its half-life is 
relatively long (109.8 minutes) allowing the preparation of complex molecules with 
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acceptable radiochemical yields. Finally, the relatively long half-life permits the 
commercialization of radiotracers as diagnostic tools in the clinical environment.  
 
Radionuclide Half-life (min) Decay mode Max. Energy (MeV) 
Fluorine-18 109.8 97% ǃ+ 3% EC* 0.69 
Carbon-11 20.4 100 % ǃ+ 0.96 
Nitrogen-13 9.98 100 % ǃ+ 1.19 
Oxygen-15 2.05 100 % ǃ+ 1.70 
Table 1. Physical characteristics of Fluorine-18, Carbon-11, Nitrogen-13 and Oxygen-15. *EC: 
Electron capture. 
Out of the above mentioned clinical environment, Nitrogen-13 and Oxygen-15 can be also 
potentially used for the synthesis of radiotracers. However, the manufacturing process of 
radiotracers with these positron emitters presents some difficulties because of their short 
half-life (9.98 and 2.05 min, respectively) and distribution of radiotracers from one 
centralized production centre to surrounding centres is not feasible.  
Despite the widespread use of these isotopes (which is reflected in a high number of 
scientific publications in which the preparation and putative applications of 18F-, 13N- and 
15O- labelled radiotracers are described) the most challenging and exciting positron emitter 
is probably Carbon-11, which in general terms cannot be transported from manufacturing 
centres to surrounding hospitals and thus began to receive increasing attention in the sixties 
due to the widespread installation of cyclotrons in hospitals and research centres. 
There are two main reasons to consider Carbon-11 as the most exciting and challenging PET 
isotope. First, carbon is present in all organic compounds, and thus a Carbon-11 analog 
(identical to the unlabelled structure) of any specific organic molecule could be potentially 
prepared, and second, Carbon-11 can be produced with good yields in two different 
chemical forms ([11C]CH4, obtained by irradiating N2/H2 mixtures; and [11C]CO2, obtained 
by irradiation of  N2/O2 mixtures (Christman et al., 1975)) which can be easily transformed 
into other radioactive precursors via well established labelling strategies to perform 
different types of chemical reactions. Thus, Grignard-type reactions to yield [carbonyl-
11C]carboxylates can be carried out by using directly cyclotron generated [11C]CO2; the latter 
can be also converted into [11C]CO through the reduction over zinc or molybdenum in an 
on-line process and further used to produce (e.g. via the palladium-mediated 
[11C]carbonylation of olefins, alkynes and organic halides) carboxylic acids (Itsenko et al., 
2006), amides (Rahman et al., 2003) and imides (Karimi et al., 2001), among others. [11C]CO2 
can be also transformed into [11C]CH3OH via reduction with LiAlH4; the latter can be 
further reacted with hydriodic acid to yield [11C]CH3I which is by far the most commonly 
used radioactive precursor for introducing Carbon-11 into organic molecules via 
nucleophilic substitution using amines (Mathis et al., 2003), amides (Hashimoto et al., 1989), 
phenols (Ehrin et al, 1985) or thiol groups (Langstrom & Lundqvist, 1976). Eventually, 
[11C]CH3I can be passed in gas phase through a silver triflate column at high temperature to 
yield [11C]methyl triflate (Jewett, 1992), which can be used as a highly reactive methylating 
agent when reactivity of [11C]CH3I is not sufficient. On the other hand, [11C]CH4 can be also 
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converted into [11C]CH3I through a gas-solid iodination reaction at high temperature. In this 
case, the iodination step is carried out in a quartz tube which contains I2 vapour at high 
temperature (Prenant & Crouzel, 1991; Larsen et al., 1997). 
This versatility of Carbon-11 as a synthetic tool has led to a immense number of publications 
in the scientific literature in which the synthetic strategies and optimization steps are 
described. As a result, nowadays there is a large variety of well established processes that 
can be followed when the radiosynthesis of a new radiotracer is approached. However, 
depending on the final application of the tracer, one strategy can be more appropriate than 
others, and one of the big challenges for radiochemists consists not only of synthesizing the 
radiotracer with good radiochemical yield and high radiochemical purity but also with a 
sufficiently high AS for a particular application.    
In this chapter, an exhaustive analysis (based on bibliographic data) of the typical values of 
AS obtained for 11C-labelled radiotracers and the main factors affecting this parameter will 
be performed. Experimental protocols to improve specific activity of 11C-labelled 
radiotracers will be described and discussed on the basis of bibliographic data and personal 
experience of the authors.   
2. Specific activity in 
11
C-labelled radiotracers 
2.1 Modulation of specific activity 
According to IUPAC definition (see above) and in the context of radiopharmaceuticals, 
specific activity can be expressed using equation (1):  
ܣ௦ = ܣ௜݊௜  (1)
Where Ai is the activity (expressed in Bq) of the radiopharmaceutical specie and ni is the 
molar amount of the sum of all radioactive and stable forms of the radiopharmaceutical. 
Usually, As is expressed, in the case of 11C-labelled radiopharmaceuticals, in GBq/µmol. 
From the equation, it is clear that specific activity can be increased either by (i) increasing 
the amount of radioactivity and/or (ii) decreasing the amount of stable forms. 
In the specific case of cyclotron produced 11C, the increase in the amount of radioactivity can 
be achieved, obviously, by producing higher amounts of radioactive precursor (e.g., 
[11C]CO2 or [11C]CH4). However, increasing the dose (integrated current) or the beam 
intensity does not always result in a higher amount of radioactivity and consequently in a 
higher specific activity of the final radiopharmaceutical. In other occasions, increasing the 
beam time increases also the incorporation of impurities. For instance, it has been reported 
that the in-target specific activity of [11C]CO2 peaked at 20-25 minutes of beam time and 
decreased with longer irradiations, due to incorporation of contamination into the target 
gas, which was faster that the net production of carbon-11 (Mock, 2006). However, in a 
certain range and in general terms, increasing irradiation time results in an increase of AS. In 
Figure 3, a set of experiments performed by the authors of this chapter (results not 
published before) are shown. Carbon-11 was produced by irradiation (target current=22 µA, 
1-8 µAh) of a gas N2/H2 mixture (95/5, filling pressure=16 bar) with high energy (~16 MeV) 
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protons. The resulting [11C]CH4 was allowed to react with iodine at 720ºC to form 
[11C]methyl iodide in a gas circulating process, to be further reacted with phenol in the 
presence of a base to yield [11C]anisole. As can be seen, higher specific activity values were 
obtained with increasing beam time. Although the curve seems to reach a plateau, the 
presence of a peak as previously reported (Mock, 2006) was not found, probably because no 
longer irradiation times were investigated.     
 
 
 
Fig. 3. Specific activity of [11C]anisole (corrected to EOB, end of bombardment) produced 
using different irradiation times.  
Besides increasing the amount of radioactivity, the other possibility to increase specific 
activity consists of decreasing the amount of stable forms, or in other words, to prevent the 
introduction of stable isotopes of carbon (mainly 12C) in any of the processes followed for 
the preparation of the radiopharmaceutical, from the production of 11C in the cyclotron till 
the final formulation of the radiopharmaceutical. These non radioactive carbon sources 
might potentially contaminate the reaction environment during radiopharmaceuticals 
preparation processes, thus decreasing the final specific activity. Actually, some of these 
sources have been known for a long time. During production of the radioactive precursor 
(irradiation), impurities in the target gas, impurities coming from the valves, pressure 
regulators, seals, target body, target windows or even residues from hydrocarbon solvents 
used to clean metal pieces after manufacturing might affect the final specific activity (Dahl & 
Schlyer, 1985). During radiotracers synthesis, incorporation of contaminants from the 
atmosphere, or release of undesired chemicals from tubes, reactors, etc. or even the presence 
of stable carbon in some of the reagents could also contribute to the decrease of final AS.   
These non radioactive sources will have different effects on the final specific activity 
depending on the particular configuration of the different equipment at each site. The effects 
will also vary depending on the synthetic process followed and the chemical structure of 
such impurities. Thus, every specific scenario should be investigated individually. However, 
the discussion of all specific scenarios and configurations is beyond the scope of this 
chapter, and only a few synthetic routes, namely, methylation reactions starting from 
cyclotron produced [11C]CO2 and [11C]CH4 (which are considered by the authors the most 
frequently used in Carbon-11 radiochemistry) will be discussed. Still, most of the concepts 
introduced in the following pages can be applied (or extrapolated) to the preparation of 11C-
labelled radiotracers by following other routes.    
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2.2 Interpretation of specific activity: Are reported values always comparable? 
If one has a solution of, for instance, [11C]Raclopride, and specific activity is not the 
theoretical value, species A, B, C and D (Figure 1) are co-existing. The specific activity will 
be given by equation (2): 
ܣௌ = ܣ஺݊஺ + ݊஻ + ݊஼ + ݊஽  (2)
Where AA is the amount of radioactivity due to the presence of specie A, and nA, nB, nC and 
nD are the molar amounts of A, B, C and D, respectively. When the specific activity of a 
radiotracer is the theoretical value (341.1 TBq/µmol for Carbon-11), nB, nC and nD are zero, 
and the value of AS value is not changing over time, because both the amount of 
radioactivity (AA) and the molar amount of A (nA) are decreasing with the same rate.  
On the other hand, when the specific activity is far from its theoretical value, then: ݊஻ +	݊஼ +	݊஽ 	≫ 	݊஺										thus,													 ܣ஺݊஺ +	݊஻ +	݊஼ +	݊஽ 		~			 ܣ஺	݊஻ +	݊஼ +	݊஽ 
As (nB + nC + nD) is (almost) constant (due to the long half life of 14C) then AS decreases at the 
same rate as AA does. In other words: Every half life, the value of AS is decreased by a factor 
of 2. Therefore, in real scenarios the values of AS have to be reported at a given time point. 
In the literature, and in the particular case of 11C-labelled radiotracers, authors usually 
report AS at the end of synthesis (EOS), end of bombardment (EOB) or end of transfer (of the 
activity, from the cyclotron to the hot cell where the radiosynthesis takes place). Values at 
EOB are usually easier to compare, because they do not depend on synthesis time and offer 
a direct estimation of the amount of stable carbon contributing to the dilution (and 
consequent decrease in AS). In some occasions, where systematic studies are performed to 
search for the sources of contamination, the total amount of carrier (which can be directly 
compared to previously published values) is reported. 
3. Specific activity of 
11
C-labelled radiotracers produced following 
methylation 
Methylation reactions consist of attaching a CH3- group (using e.g. CH3I or CH3OTf) to a 
nucleophile (usually an oxygen, nitrogen or sulphur atom) via the SN2 reaction pathway. 
When 11C-labelled radiotracers are prepared by following this route, [11C]CH3I cannot be 
produced directly in the target in large amounts (Wagner et al., 1981) and has to be 
synthesized from other synthetic precursors, namely [11C]CO2 or [11C]CH4. Both schemes 
will be discussed separately.    
3.1 Methylation reactions starting from cyclotron produced [
11
C]CO2  
3.1.1 [
11
C]CO2 production 
The irradiation of nitrogen gas at sufficient beam (proton) energies yields large amounts 
of [11C]CO2. During irradiation, 14N is converted into 11C via the 14N(p, ǂ)11C nuclear 
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reaction, with the highest cross-section at 7.5 MeV. According to Christman and co-
workers, it is unnecessary to add oxygen to the nitrogen gas, because trace amounts of 
oxygen already present in the nitrogen (~1 ppm) are sufficient for the oxidation reaction 
to occur. They reported that, when oxygen was added to the system, copious amounts of 
nitrogen oxides were produced in addition to the desired [11C]CO2, from the reaction 
16O(p, ǂ)13N and from radiolysis processes. According to previous reports (Ache & Wolf, 
1968) the primary products resulting from the reactions of “hot” carbon atoms with 
nitrogen-oxygen mixtures at low radiation doses are cyanide and carbon monoxide. The 
oxidation of these two primary products as a function of the radiation dose by the proton 
beam are not fully known, but in any case, the final product obtained from this system 
was shown to be over 90 per cent 11[C]CO2, without the incorporation of any chemical 
oxidation. 
Currently, [11C]CO2 is still produced in similar targets to those described by Christman et 
al., although 0.5-2% oxygen is added to the target gas and some improvements have been 
incorporated; it was demonstrated (Ferrieri et al., 1993) that the interaction between beam 
and target walls (independently of the material used for the manufacture of the target) 
produced the release of non radioactive carbon into the target gas mixture, decreasing thus 
specific activity. Thus, the use of targets with minimal surface exposure to beam is 
preferred. Also, and due to multiple scattering suffered by the beam through the foil 
window and in the gas, a conical-shaped target (a cylindrical target was used in previous 
experiments conducted by Christman’s group) was proposed (Schlyer & Plascjak, 1991). The 
conical target is still the standard model supplied with some commercial cyclotrons.   
3.1.2 [
11
C]CH3I production and methylation 
The general reaction pathway followed for the preparation of 11C-labelled 
radiopharmaceuticals via methylation using [11C]CH3I (or [11C]CH3OTf) produced from 
[11C]CO2 (historically named the “wet method”) can be summarized in 6 steps: 1 (i) [11C]CO2 
is generated in a cyclotron via the 14N(p,ǂ)11C nuclear reaction by bombarding a N2/O2 
mixture with high energy protons; (ii) the target content is transferred to a hot cell and 
trapped in a molecular sieve column (Mock et al., 1995) at room temperature or in a cold 
trap (liquid nitrogen); (iii) the reactor is prefilled with lithium aluminium hydride solution; 
(iv) [11C]CO2 is released by increasing the temperature of the trap and bubbled (with the 
help of an inert gas) in the reactor; (v) After complete trapping, solvent is evaporated to 
dryness and hydriodic acid (aqueous solution) is added to generate [11C]CH3I which is 
distilled by heating under continuous nitrogen flow and (vi) [11C]CH3I is trapped in a 
reactor prefilled with the adequate precursor, where methylation takes place. Along this 
process, the formation of the non-radioactive specie (this is, [xC]CH3I, where xC is any stable 
isotope of carbon) is due to the presence, incorporation and/or in situ generation of [xC]CO2 
before the treatment with hydriodic acid. The specific sources of such xC in real scenarios 
and the individual contribution of each one to the decrease of final specific activity have 
been historically profoundly discussed.  
                                                                 
1 [11C]CH3I can be also produced from [11C]CO2 via reduction over a nickel catalyst at high temperature 
and further reaction with I2 (“gas phase” method). This reaction pathway will be considered later on.   
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3.1.3 Search for the sources of 
12
C in methylation reactions starting from [
11
C]CO2 via 
the wet method 
In one of the first reviews in which different sources of carrier carbon were considered 
(Crouzel et al., 1987) practical recommendations to attain molar activities of 75–
175GBq/µmol routinely were suggested. These recommendations included: (i) using  (small 
and properly washed) aluminum targets with Havar, stainless steel or titanium foils, (ii) 
using high purity target gases with a purification trap installed between the target and the 
gas supply, (iii) using metal (stainless steel or copper) tubing between the gas supply and 
target, (iv) performing short irradiations with as high a beam current as possible and (v) 
using the smallest possible amount of LiAlH4, preferably dissolved in dry (distilled from 
sodium or potassium) THF. The authors suggested that most of the stable CO2 was coming 
from the target under irradiation conditions.   
One of the first systematic studies searching for the sources of carrier carbon in 11C-labelled 
radiotracers produced from [11C]CH3I synthesized from cyclotron generated [11C]CO2 was 
performed 1 year later (Iwata et al., 1988). Although the authors suspected in a first step that 
LiAlH4 (solution in THF) was the main source of carrier (LiAlH4 can absorb CO2 from the 
environment when not stored/prepared under rigorous inert atmosphere), the total carrier 
amount was not so much reduced as expected with decreasing the concentration of LiAlH4 
solution. This fact led them to postulate that a significant amount of carrier might come 
from the [11C]CO2 production system (the target), although no significant correlation 
between the total carrier amount and the volume of the target gas was observed.  Finally, 
they concluded that carrier carbon dioxide was mostly originated in the methanol formed 
from a trace of THF remaining in the LiAlH4 after the evaporation step, and could be 
decreased significantly (up to a certain limit) by reducing the amount and concentration of 
the LiAlH4/THF solution. They concluded that it might be very difficult to overcome this 
limit, and thus increasing starting 11C-activity and shortening the synthesis time were 
proposed to be the most adequate solution to achieve higher specific activities.  
In a more recent work (Matarrese et al., 2003) another systematic study of the different 
factors introducing carrier carbon was performed. Although the authors concluded that the 
critical point to obtain high specific radioactivity was the minimization of lithium aluminum 
hydride quantity (see table 2 for relation of AS and quantity of LiAlH4 solutions obtained by 
Matarrese’s group), different modifications were also introduced to the commercial 
Synthesizer to improve the specific activity. The original reaction vessel design was 
modified and the tube inlets were accomplished by standard male-luer fittings with 
disposable needles, while carrier gas flows (the purge gas lines leading to reaction vessels 
and to dispensing vessels and solid phase extraction unit) were separated, thus allowing the 
use of different gases for these two purposes. Besides, several routine operations were 
included before syntheses, mainly: (i) the target was flushed with the target gas mixture (at 
least 10 target volumes) prior to bombardment; (ii) a leak-test was performed on the liquid 
nitrogen loop, [11C]CO2 trapping reaction vessels and connecting tubes; (iii) reaction vessels 
and liquid nitrogen trap were dried at 150 °C for 30 minutes by a continuous argon flow 
(100 mL/min); (iv) the PTFE [11C]CO2 delivery lines connecting the target with the module 
were continuously flushed with a stream of helium during bombardment and (v) the 
metallo-organic trapping solution (LiAlH4/THF) was added into the reaction vessel 
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immediately before unloading the [11C]CO2 target with the sample-lock gas-tight syringe. As 
can be seen in the table, good specific activity values were reached, especially when the 
optimal amount of LiAlH4 solution was used, although such values were reported at EOS 
and synthesis time was not reported; therefore, recalculation at EOB is not possible. 
  
Radioligand Yield EOB (%) AS EOS (GBq/µmol) LiAlH4 (µmol) 
[11C](R)-MDL-100907 55 ± 10 70 ± 30 10 
[11C](R)-MDL-100907 60 ± 20 315 ± 89 7 
[11C](R)-MDL-100907 54 ± 10 392 ± 166 6 
[11C](R)-MDL-100907 53 ± 10 322 ± 181 5 
Table 2. Relation between specific radioactivity of [11C](R)-MDL-100907 and quantity of the 
LiAlH4/THF solutions.  
Five years later (Ermert et al, 2008), a different strategy for the preparation of [11C]CH3I (in 
which [11C]CO2 from the target chamber was reduced by a lithium aluminum hydride 
solution, and the methanol obtained on-line was converted using triphenylphosphine 
diiodide) was reported. [11C]CH3I was transformed into [11C]MeOTf via on-line conversion 
to synthesize [11C]TCH346. Six batches of this radiotracer were prepared within 10 days and 
specific activity values of 40, 330, 1700, 280, 770 and 5700 GBq/µmol for syntheses 1-6, 
respectively, were obtained. All syntheses were carried out using the same flask of 
commercially available lithium aluminum hydride solution repetitively; as the specific 
activity increased during the course of the synthesis campaign, the authors concluded that 
essential dilution by stable carbon via the LiAlH4-solution could nearly be excluded, or at 
least equally important carbon sources appeared to be the target chamber and the 
penetration of ambient air into the target line and the synthesis unit. In any case, the 
aforesaid specific activities are higher than those earlier reported and are probably the 
highest values ever reported for 11C-labelled radiotracers prepared by following this 
synthetic approach. 
Almost simultaneously to the paper reported by Ermert and co-workers, and encouraged by 
this historical disagreement suggesting that the sources of contamination were extremely 
dependent on the particular configuration of the systems involved in the production process 
of each particular site (e.g. quality of the reagents and irradiated gases, target material, 
synthesis box, etc.) an exhaustive analysis of the potential sources of non radioactive carbon 
and their individual contribution to the final specific activity was carried out by some of the 
authors of this chapter (Gómez-Vallejo et al., 2009). In these studies, four synthetic scenarios 
were defined: (a) syntheses were carried out by executing steps (iii) and (v) of the previous 
general procedure; (b) syntheses were run by executing steps (iii), (iv) and (v); (c) syntheses 
were run by executing steps (ii), (iii), (iv) and (v) and (d) syntheses were run by executing all 
steps included in the general procedure. To assess also the effect of  bombarding time on the 
final amount of [xC]CH3I, different experiments were carried out at different integrated 
currents (1, 2, 3 and 10 µAh; scenarios d1-d4, respectively).  
Under Scenario (a) (where the contribution to the production of stable methyl iodide should 
come from the presence of CO2 absorbed in LiAlH4 solution, methanol formed from THF 
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remaining in the LiAlH4 after evaporation step and/or direct CO2 incorporation from the 
atmosphere during the synthesis process due to the lack of tightness of the synthesis 
module) only 15.5 ± 2.7 nmol of non-radioactive CH3I were generated (Figure 4B). Under 
scenario (b) conditions (where the contribution of absorbed CO2 in the molecular sieve was 
also considered), 45.8 ± 11.7 nmol of CH3I were generated. Under scenario (c) conditions 
(where also the contribution from loading and unloading the target was considered, thus 
CO2 should come from carbon dioxide absorbed either in the target chamber or in the 
stainless-steel tubing connecting the target with the synthesis box, and present as an 
impurity in the target gas), 78.5 ± 12.3 nmol of CH3I were detected (Figure 4B). Under 
scenario (d), 537.9 ± 197.5, 832.8 ± 56.3, 907.4 ± 28.2 and 1067.2 ± 59.3 nmol of methyl iodide 
were obtained for integrated currents of 1, 2, 3 and 10 µAh, respectively (scenarios d1-d4, 
Figure 4B). These results show that the generation of stable methyl iodide under scenarios 
(a), (b) and (c) is minor when compared to the contribution of bombarding processes during 
irradiation (see Figure 4A for individual contribution of the sources considered at each 
scenario). On the other hand, there is a non-linear trend between the increase in the amount 
of [xC]CO2 and the increase in integrated current in the target (Figure 4A), suggesting that 
the decrease in specific activity is probably due to the presence of carbon carrier 
contamination which undergoes combustion (High temperature, estimated around 260ºC 
and pressure, around 38 bar, are reached into the target chamber during bombardment) 
mainly during the first minutes of irradiation. This effect of beam integrated current on the 
amount of stable carbon was also reported by other authors (Mock, 2006).  
 
 
 
Fig. 4. Amount (in nmol) of [xC]CH3I generated under scenarios (a), (b), (c) and (d).  
Individual contribution of the factors considered in each scenario (A) and cumulative 
contribution (B). 
In view of these results, some general procedures (which should help to improve the specific 
activity of Carbon-11 labelled compounds synthesized by the wet method) were suggested, 
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including: i) loading/unloading (through transfer line into the molecular sieve) the target 
several times (with the aim of transferring all CO2 contamination present in the target 
chamber and/or the transfer line into the molecular sieve); ii) loading/bombarding 
(integrated current = 1 ǍAh, target current = 24 ǍA)/unloading (to waste) the target three 
times (to “burn” all carbon compounds presumably present in the target chamber); iii) 
preconditioning (t = 60 minutes, T = 250ºC, continuous N2 flow = 50 mL/min) the molecular 
sieve column (to eliminate CO2 from the molecular sieve); iv) cleaning 
(ethanol/acetone/diethyl ether) and drying (N2) the synthesis box and keeping the system 
pressurized after drying to avoid atmospheric contamination; v) using commercially 
available LiAlH4/THF solution and vi) minimizing the amount of LiAlH4/THF solution 
used per run; furthermore, keeping the target loaded (P = 21 bar) between two consecutive 
productions and periodical inspection of general connections and tubing should help in the 
prevention of external contamination in the target chamber, the transfer line and the 
synthesis box.  
Although by implementing these steps moderate specific activity values could be achieved 
in the preparation of e.g. [11C]Raclopride (23.2 ± 11.7 GBq/Ǎmol at EOS, 128 ± 64 GBq/Ǎmol 
at EOB (Catafau et al., 2009)), such values were still far from those reported by Ermert and 
coworkers in 2008. This is probably due to the fact that the purity of the gases was not 
considered in the study conducted by Gomez-Vallejo et al., and no purification steps before 
loading the target were implemented. Also, no specific cleaning of the target chamber was 
performed before the experiments. In any case, the values obtained by Ermert’s group are 
very far from average specific activities reported in the literature (see table 5); thus, a 
profound analysis of the specific configuration (and preparation procedures) used by this 
group could help to get more consistent conclusions related to the sources of non 
radioactive carbon and the protocols to be followed in order to increase AS.  
One of the lasts works focused in improving specific activities in [11C]CO2 production was 
reported recently (Eriksson et al., 2009). Three consecutive test periods were carried out 
with a standard IBA aluminum target, using 4 different configurations: a) Previously not 
irradiated target body, using a new window foil with nitrile o-ring; b) used foil with silver 
o-ring; c) new foil with silver o-ring and d) same basic build as (c) but with nickel plating 
on the aluminum surface. For configurations (a), (b) and (c) an increase in AS of 2.4-2.5 
GBq/Ǎmol per ǍAh was observed for second and third production of a series of 
consecutive runs (results that are consistent with those reported by Gómez-Vallejo et al.), 
while for (d) the increase was significantly faster (5.4 GBq/Ǎmol per ǍAh). After several 
irradiations, a plateau was found for all configurations, but (d) gave better specific 
activities (2540 ± 190 GBq/µmol) than (a) and (c) (2010 ± 310 GBq/µmol and 1920 ± 220 
GBq/µmol, respectively).2 The specific activity obtained with (d) could be even improved 
by connecting the helium line (used for activity transfer from cyclotron) only to the 11C 
target (values up to 5400 ± 1700 GBq/µmol). Thus, nickel plating on the aluminum surface 
and using high purity gases (isolated from atmosphere or potential contamination 
sources) seem to have a positive effect on specific activity values obtained when the wet 
method is used.   
                                                                 
2 Configuration (b) developed a target leak before the plateau was established. 
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3.2 Methylation reactions starting from cyclotron produced [
11
C]CH4  
3.2.1 [
11
C]CH4 production 
The irradiation of nitrogen/hydrogen gas mixtures at sufficient beam (proton) energies 
yields large amounts of [11C]methane (Christman et al., 1975). During irradiation, 14N is 
converted into 11C via the 14N(p, ǂ)11C nuclear reaction (Epherre and Seide, 1971). From the 
reaction of hot recoil carbon atoms with nitrogen molecules, [11C]CN and [11C]CN2 can be 
produced (Dubrin et al., 1964), and of these [11C]CN is the most probable final stable species. 
Upon the addition of small amounts of hydrogen to the target gas, a second (and very fast) 
reaction gives [11C]HCN (Ache & Wolf, 1968), which is readily reduced via a radiation 
induced mechanism to yield [11C]CH4. Unfortunately, increasing the beam current and 
irradiation lengths results in a significant drop in the amount of [11C]CH4, probably due to 
beam-wall interactions and high probability of the radioactive species sticking in the target 
walls, resulting in a reduction in recoverable yield. Due to these observed interactions with 
the target walls, large volume targets (flow through design in some cases) where beam wall 
interactions are less likely, produce results more in line with theory. Thus, the choice of 
target material in small- to medium-sized targets is therefore proposed to be one of the most 
important factors for optimizing [11C]methane yields (Koziorowski et al., 2010). Buckley et 
al. (2004) explored the viability of using a niobium target chamber with a cylindrical shape 
(15 mm in diameter and 120 mm in length, energy of the proton beam = 12 MeV) for the 
production of [11C]CH4 from a gas mixture of N2/H2; 95/5 and 90/10. In table 3, the amount 
of radioactivity (in GBq) and saturation yields (in GBq/µA) for 20 µA irradiations are 
shown.  
 
Time (min) Yield (GBq)* Saturation Yield (GBq/µA) 
5 12.47 3.66 
10 20.02 3.29 
20 32.19 3.18 
30 39.22 3.03 
40 43.81 2.92 
60 48.47 2.78 
Table 3. Target yields in GBq and production rate at saturation in GBq/µA for the 
production of [11C]CH4 at 20 µA for the Nb chamber (loaded with N2/H2; 90/10). Nominal 
target loading pressure was 2067 kPa.  
When beam was performed on 5% hydrogen at 20 µA for 20 min, 26.94 GBq (EOB) were 
produced (saturation yield of 2.70 GBq/µA). These results are not as good as the 10% values 
(32.19 GBq, 3.18 GBq/µA) but comparable to 10% results reported for the aluminum target 
chamber. Although the yields from the niobium target chamber were found to be better than 
those from the aluminum target chamber, the production rate was found to diminish with 
time. 
In a recent work, the use of quartz as a target material (due to its chemical inertness) was 
proposed (Koziorowski et al., 2010); the use of such material should also improve the 
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specific activity of produced [11C]CH4 due to its low carbon content and the fact that it is 
manufactured without the use of any potential carbon sources, such as lubricants. In this 
work, the authors designed and constructed a target based on an aluminum body fitted with 
a quartz liner. A mixture N2/H2 (90/10) was used (filling pressure = 26 bar). As previously 
reported, an increasing deviation from theoretical yields with increased irradiation dose 
(ǍAh) was seen (see Figure 5), both when irradiation time and irradiation current were 
increased. The authors concluded that this drop in yields should be explained by the 
presence of radioactive species adsorbed to the target, although the underlying 
mechanism(s) of this phenomenon has yet to be elucidated. 
  
Fig. 5. (A) Theoretical and production yields expressed as GBq at EOB with a beam current 
of 25 ǍA. Theoretical yield (●); target with quartz insert (▲); target without quartz insert (■); 
(B) Production yields expressed as percentage of the theoretical yield for 10 ǍA with (■) and 
without quartz insert (●) and for 25 ǍA with (▲) and without quartz insert (). 
Buckley et al. (2004) had previously proposed an exponential equation which target 
production data could be fitted to: 
Y = A e-at I SF (3)
Where Y is the decay-corrected yield (mCi), A the fitted pre-exponential term (mCi/ǍA, 
term representing production rates in the target), a the fitted exponential term (min−1, 
representing losses due to activity retained in the target), I the beam current, t the irradiation 
time (min) and SF the saturation correction factor (1−e−ǌt).  
The results obtained after fitting the data obtained by Koziorowski and coworkers are 
shown in Table 4, and compared to those previously obtained with the niobium target 
(Buckley et al., 2004). As can be seen, the quartz-lined target chamber performs well 
compared with the niobium target chamber, while the pure aluminum chamber performs 
slightly less well.   
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Target chamber A a (x 10000) 
Niobium cylinder† 95 ± 2 40 ± 4 
Quartz-lined aluminum cylinder‡ 170 ± 6 45 ± 11 
Aluminum cylinder* 168 ± 10 85 ± 26 
Aluminum cone* 78 ± 9 135 ± 44 
Nickel cone* 65 ± 9 527 ± 67 
Stainless Steel cylinder* 71 ± 11 64 ± 62 
Large Aluminum cylinder* 70 ± 9 180 ± 52 
Table 4. Fitted parameters A and a for targets used for production of [11C]CH4.  †Buckley et 
al., 2004; ‡ Koziorowski et al., 2010; * Buckley et al., 2000. 
3.2.2 [
11
C]CH3I production and methylation 
The general reaction pathway followed for the preparation of 11C-labelled 
radiopharmaceuticals via methylation using [11C]CH3I (or [11C]CH3OTf) produced from 
[11C]CH4 can be summarized in 5 steps: (i) [11C]CH4 is generated in a cyclotron via the 
14N(p,ǂ)11C nuclear reaction by bombarding a N2/H2 mixture with high energy protons; (ii) 
the target content is transferred to a hot cell and trapped in Carbosphere 60/80 at low T 
(approximatelly-140ºC); (iii) [11C]CH4 is desorbed by heating (~80ºC) and allowed to react 
with iodine at 720ºC to form [11C]methyl iodide in a gas circulating process. At this step, due 
to the low efficiency of the iodination reaction, [11C]methyl iodide is selectively retained in a 
trap (PorapakTM Q, 50-80 mesh) at room temperature, while unreacted [11C]CH4 is allowed 
to recirculate until reaction is complete (~80% conversion). (iv) After several recirculations, 
the PorapakTM Q trap is heated (~190ºC) and [11C]methyl iodide is distilled under 
continuous inert gas flow (20 mL/min); (v) the gas stream is directed to a reactor pre-filled 
with a solution of the precursor and methylation reaction takes place. A single pass gas 
phase method (where [11C]CH4 is not recirculated but reacted with I2 in a single step) was 
first reported (Prenant & Crouzel, 1991). Later the method was improved by changing the 
single-pass to recirculation, starting with either cyclotron produced  [11C]CO2 (converted to 
[11C]CH4  by hydrogen reduction in the presence of a nickel catalyst) or[11C]CH4 (Larsen et 
al., 1997) reporting yields up to 83%, decay corrected. 
3.2.3 Search for the sources of 
12
C in methylation reactions starting from [
11
C]CO2 and 
[
11
C]CH4 via the gas phase method 
When the latter procedure (reduction of [11C]CO2 with a catalyst to produce [11C]CH4) is 
used, the same problems associated to the introduction of carrier carbon as in the case of  
producing [11C]CH3I from [11C]CO2 via the wet method can be found: (i) CO, CH4 and other 
carbon sources in the target gas can be transformed into CO2 during irradiations and (ii) 
CO2 absorbed on the inner surface of the target chamber or transfer lines can be released to 
the reaction environment. By using this method, Mock (2006) reported a maximum in 
specific activity of ~925 GBq/µmol, by using a RDS-111 Eclipse cyclotron and bombarding 
N2/O2; 99/1 mixture. The amount of carrier in the irradiated gas increased with irradiation 
time and also when the target remained pressurized (even without irradiation). Moreover, 
specific activity dropped for irradiations > 20µAh due to excessive carrier release from the 
target.  
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To overcome the problems associated to the use of [11C]CO2 at any step of the synthesis, an 
automated synthesis device using the single pass I2 method coupled with the in situ 
[11C]CH4 production method (irradiation of N2/H2; 95/5) was developed, and the 
experimental conditions for the production of ultra high specific activity [11C]CH3I were 
optimized (Noguchi & Suzuki, 2003). The target body (aluminum A5056, metallic seal, 
length 150 mm, inlet aperture 20 mm, outlet aperture 30 mm) was carefully machined 
without oil and polished with sandpaper AA-400. All the parts for the target assembly were 
washed with HCl, Milli-Q water and acetone, and dried at 350°C under vacuum. The target 
chamber was then assembled quickly in an air-tight glove box filled with pure N2 gas and 
connected to the production line. The production route was cleaned carefully by sweeping it 
under heating with a target gas or helium. Before irradiation for the production of 
radiotracers, the target chamber was loaded/unloaded a few times without irradiation and 
three times with irradiation (20 µA, 5 minutes). By following this procedure, specific 
activities of 4700 ± 2500 GBq/µmol (2900-9700 GBq/µmol) were achieved. However, as 
reported later (Zhang & Suzuki, 2005), an immediate decrease of such values was 
occasionally encountered. The authors analyzed the sources of carrier carbon in the 
previously developed system, assuming that some organic reagents (contaminants in the 
synthetic line) may react with I2 vapor to yield CH3I in the heated quartz tube, resulting in a 
significant decrease of the specific activity of [11C]CH3I. The authors found that traces of 
organic reagents, such as acetone, methanol, silicone oil and paraffin, reacted with I2 to yield 
CH3I in the heated quartz tube, resulting in a significant decrease of the specific activity of 
[11C]CH3I. Therefore, prior to production, sufficient washing and drying of the device 
components and sufficient flushing of the synthetic lines with a pure inert gas were 
suggested to improve specific activity. In this sense, Koziorowski & Gillings (2010) found 
that when specific activity of (cyclotron generated) CH4 was measured by on-line 
conversion to HCN, values higher than 13000 GBq/µmol were encountered. These results 
suggest that the AS of 11C-labelled radiotracers synthesized by the gas phase method is 
lowered downstream from the target, i.e. during [11C]CH4 to [11C]CH3I conversion, which is 
consistent with the results of Zhang & Suzuki (2005). 
Recently, a quartz-lined aluminum target for the production of [11C]methane was developed 
(Koziorowski et al., 2010). On top of producing [11C]CH4 in excellent yields and reducing 
losses of radioactivity significantly (when compared with the aluminum target), the authors 
were able to produce radiopharmaceuticals with specific radioactivities up to 9000 
GBq/Ǎmol at end of bombardment (EOB). In Figure 6, the values of specific activity 
obtained by Koziorowski’s group are depicted.  These values were initially (already) a factor 
of four to five higher compared with the conical, aluminum 750 mL volume target. By 
installing an inline gas purifier, the specific activities further increased. Additionally, 
specific activity was seen to increase with repeated irradiations and radiosyntheses on the 
same day. This fact (which can be attributed to a conditioning effect) has been seen also by 
the authors of this chapter in a recently performed set of experiments with an Aluminum 
target (Unpublished results). Seven consecutive 0.25 µAh irradiations were performed in an 
aluminum target filled with N2/H2; 95/5 (P = 16 atm) at 22 µA. As can be seen in Figure 7A, 
the specific activity (corrected to EOB) increased from ~61 GBq/µmol (beam number 1) up 
to ~571 GBq/µmol (beam number 7) within one day. When experiments were performed 
the following day, the same pattern was obtained. A plateau seems to be achieved after 4 
runs, which is a clear indication that contamination in the surface of the target 
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walls/window is accumulated while the target is not used (it is maintained unpressurized) 
and is slowly released as the number of experiments increase. In a second set of 
experiments, three consecutive irradiations (under the experimental conditions stated 
above) were performed but the target was kept pressurized (P = 16 bar, N2/H2; 95/5) 
overnight to prevent contamination from the atmosphere. Higher values of AS were 
obtained even in the first irradiation of the day (~ 557 GBq/µmol) and were maintained in 
consecutive runs (Figure 7B). Although the performance of the target was not (apparently) 
affected in terms of amount of activity obtained at the end of the synthesis, more 
experiments are still required to assess the potential degradation of the target due to long 
term exposure of Aluminum to the N2/H2 mixture.   
 
Fig. 6. Specific activities of [11C]radiopharmaceuticals (EOB) produced from [11C]methane. 
 
 
 
Fig. 7. (A) Specific activities of [11C]anisole (EOB) produced from [11C]methane within 1 day 
(integrated current = 0.25 µAh, beam intensity = 22 µA, filling pressure = 16 atm, aluminium 
target). (B) Specific activities of [11C]anisole (EOB) produced from [11C]methane within 1 day 
(same irradiation conditions, target filled with N2/H2 overnight). 
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4. General discussion and conclusions 
As can be concluded from all the previous works, the discussion regarding the origin of non 
radioactive carbon and the procedures to minimize contamination effects (independently of 
the production process followed to generate carbon-11 and the reaction pathway followed 
afterwards) have been lasting for years. Although different sources have been encountered 
and their individual contribution somehow quantified, it seems clear that the final specific 
activity of 11C-labelled radiotracers is extremely dependent of site-specific configuration and 
minimal alteration of experimental conditions can lead to considerable effects on specific 
activity values, especially when such specific activities are high. 
Tables 5 and 6 show specific activity values reported in the literature for syntheses of 11C-
labelled radiotracers synthesized either from cyclotron generated [11C]CO2 or [11C]CH4 
using either the wet method or the gas phase method. It is absolutely impossible to include 
every single reported value, and thus a selection has been performed while trying to include 
representative data. In order to get comparable results, values at EOB are shown, although 
values at EOS are also included. In the case that one of the values was not reported in the 
original publications but synthesis time was included, decay corrected values have been 
calculated and included in the tables. 
As can be seen in table 5, specific activity values (EOS) are in the range 5.92-357 GBq/µmol 
(except for entrance 16, where extremely and unusually high AS values were obtained, as 
discussed above). In most cases where high values (relative to average) were reported, 
specific procedures to prevent external contamination were applied. Thus, Matarrese and 
co-workers (2003) obtained high AS values at EOB (217-357 GBq/µmol) by optimizing the 
amount of LiAlH4 solution, flushing the target with gas several times before beam, checking 
(and correcting) leaks, carefully cleaning and drying the synthesis system and flushing the 
lines from the cyclotron to the synthesis boxes continuously during irradiations. However, 
no special actions were taken with the target itself. When these results are compared to 
those included in table 6, it can be concluded that higher specific activity values are obtained 
(in general terms) when the gas phase method is used, independently of the radioactive 
specie generated in the cyclotron (62-740 GBq/µmol for [11C]CO2, 74-5479 GBq/µmol for 
[11C]CH4), although higher values are obtained when cyclotron generated [11C]CH4 is used. 
This is due, partially, to the high concentration of CO2 in the atmosphere which constitutes 
an important source of contamination. For instance, by switching from [11C]CO2 target to the 
[11C]CH4 target and using the gas phase method in both cases, a 6-17 fold increase of specific 
activity was found in the preparation of some 11C-labelled radiotracers ([11C]Raclopride, 
[11C]MADAM, [11C]PE2I and [11C]FLB457 (Andersson et al., 2009)). In this case, the authors 
attributed this finding to [11C]CO2 being more sensitive to isotopic dilution from CO2 in the 
air, than what the influence of environmental contamination of CH4 is likely to have on the 
specific activity. Considering that the concentration of CO2 and CH4 in air are 365ppm and 
1745ppb, respectively, a 200 times higher specific activity would be expected when using 
[11C]CH4. As long as the mentioned 200-fold increase is never found in real conditions, one 
can conclude that specific activity is lowered by carbon introduced not only from the air, but 
also from the system, all the way from the target gas to the reaction vessel. This is consistent 
with all previous works that have been referenced all along this chapter. 
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Entry Radiotracer 
AS EOB 
(GBq/µmol)
AS EOS 
(GBq/µmol)
Cyclotron Reference 
1 [11C]DMT 13.32‡ 3.4 18 MeV 
Iwata et al., 
1988 
2 [11C]MPTP 5.92‡ 1.51 18 MeV 
Iwata et al., 
1988 
3 Dilthiazhem 8.51‡ 2.17 18 MeV 
Iwata et al., 
1988 
4 [11C]YM-09151-2 37‡ 9.44 18 MeV 
Iwata et al., 
1988 
5 [11C]CH3I 219 ± 88 185 ± 74 CTI-RDS-112 
Matarrese et 
al., 2003 
6 
[11C]m-hydroxy-
ephedrine 
357 ± 103 152 ± 44 CTI-RDS-112 
Matarrese et 
al., 2003 
7 [11C]Flumazenil 304 ± 43 129.5 ± 18.5 CTI-RDS-112 
Matarrese et 
al., 2003 
8 [11C]PNU 167760 217  ± 87 92.5  ± 37 CTI-RDS-112 
Matarrese et 
al., 2003 
9 [11C]VC-195 258 ± 103 92.5 ± 44 CTI-RDS-112 
Matarrese et 
al., 2003 
10 [11C](R)MDL-100907 - 392 ± 166 CTI-RDS-112 
Matarrese et 
al., 2003 
11 
11C-labelled 
Adrenoceptor 
antagonists 
70 - 
Scanditronix 
RNP 16 
Balle et al., 
2004 
12 
11C-labelled (S)-
thionisoxetine 
74-111 22-33 IBA 18 MeV 
Filannino et 
al., 2007 
13 [11C]CH3I 42‡ 30 IBA 18 MeV 
Gómez-Vallejo 
et al., 2009 
14 [11C]DAC 37-170 - CYPRIS HM18 Yui et al., 2011 
15 [11C]Verapamil 100-170 - CYPRIS HM18 Yui et al., 2011 
16 [11C]TCH346 40-5700 GE PETtrace* 
Ermert et al, 
2008 
17 [11C]SKF 75670 86-305 26-92 
Scanditronix MC 
17 
Da Silva et al., 
1996 
18 
11C-labelled 1-methyl-
4-piperidyl-4'-
fluorobenzoate 
- 26 TCC CS30 
Bormans et al., 
1996 
19 [11C]ketamine 13-17 3.3-4.2 Not specified 
Shiue et al., 
1997 
20 [11C]SKF 82957 115 37 
Scanditronix MC 
17 
Da Silva et al., 
1999 
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Entry Radiotracer 
AS EOB 
(GBq/µmol)
AS EOS 
(GBq/µmol)
Cyclotron Reference 
21 [11C]MeNER 82-153 35-65 
Scanditronix MC 
17 
Wilson et al., 
2003 
22 [11C]DAA1106 191-331 90-156 CYPRIS HM18 
Zhang et al., 
2003 
23 
11C-labelled MAO-B 
imaging agents 
145 37 Not specified 
Vasdev et al., 
2011 
24 [11C]DACA 163 41.5 Not specified 
Brady et al., 
1997 
25 [11C](L)-deprenyl 37 - 
Japan Steel 
works 41-inch 
Ferrieri et al., 
1999 
26 
11C-labelled flutamide 
derivatives 
- 148 Not specified 
Jacobson et al., 
2006 
Table 5. Specific activity values reported in the literature for 11C-labelled radiotracers 
synthesized from [11C]CO2 and wet method. ‡corrected to end of transfer of activity, transfer 
time 3-12 min. *Modified target gas according to Qaim et al., 1993.  
 
Entry Radiotracer Precursor†
AS EOB 
(GBq/µmol)
AS EOS 
(GBq/µmol)
Cyclotron Reference 
1 [11C]MHED [11C]CO2 444 360 13 MeV Link et al., 1997 
2 [11C]Ro-15-4513 [11C]CH4 4700 ± 2500 2000 ± 1060 
HM18 
cyclotron
Noguchi & 
Suzuki, 2003 
3 [11C]Raclopride [11C]CH4 74-370 - TR13 
Buckley et al., 
2004 
4 [11C]Flumazenil [11C]CH4 5730 2440 
CYPRIS 
HM18 
Zhang & 
Suzuki, 2005 
5 [11C]HOMADAM [11C]CO2 221.1 28.5 
Siemens 
RDS 112
Jarkas et al., 
2005 
6 [11C]Raclopride [11C]CH4 4880 ± 2360 1690 ± 818 
CYPRIS 
HM18 
Noguchi et al., 
2008 
7 [11C]raclopride [11C]CO2 124 36,27 
GEMs 
PETtrace
Andersson et 
al., 2009 
8 [11C]raclopride [11C]CH4 2335 784,67 
GEMs 
PETtrace
Andersson et 
al., 2009 
9 [11C]MADAM [11C]CO2 162 50,74 
GEMs 
PETtrace
Andersson et 
al., 2009 
10 [11C]MADAM [11C]CH4 2332 836,53 
GEMs 
PETtrace
Andersson et 
al., 2009 
11 [11C]PE2I [11C]CO2 183 59,31 
GEMs 
PETtrace
Andersson et 
al., 2009 
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Entry Radiotracer Precursor†
AS EOB 
(GBq/µmol)
AS EOS 
(GBq/µmol)
Cyclotron Reference 
12 [11C]PE2I [11C]CH4 1097 683,54 
GEMs 
PETtrace
Andersson et 
al., 2009 
13 [11C]FLB457 [11C]CO2 176 61,07 
GEMs 
PETtrace
Andersson et 
al., 2009 
14 [11C]FLB457 [11C]CH4 1313 439,28 
GEMs 
PETtrace
Andersson et 
al., 2009 
15 Not especified [11C]CH4 5479 ± 1735 - 
Scanditro
nix MC 
32 
Koziorowski et 
al., 2010 
16 [11C]DAC [11C]CH4 3670-4450 - 
CYPRIS 
HM18 
Yui et al., 2011 
17 
11C-labelled 
styryl dyes 
[11C]CO2 173.76-260.65 74-111 
CTI 11 
MeV 
Siemens
Wang et al., 
2009 
18 
11C-labelled 
tetrahydroiso-
quinoline 
derivatives 
[11C]CO2 148-222 63-94.54 
CTI 11 
MeV 
Siemens
Wang et al., 
2007 
19 
11C-labelled 
tetrahidroiso-
quinolinium 
derivatives 
[11C]CO2 62-123.50 37-74 
CTI 11 
MeV 
Siemens
Gao et al., 2008 
Table 6. Specific activity values reported in the literature for 11C-labelled radiotracers 
synthesized via gas phase method (starting either from [11C]CH4 or [11C]CO2). 
Although (as previously discussed) the sources of contamination are extremely dependent 
on the particular configuration of the systems involved in the production process of each 
particular site, and despite the everlasting discussion among scientists to find out (and 
control) the main factors contributing to a decrease in the specific activity of 11C-labelled 
radiotracers, there are general procedures that, independently of the employed radioactive 
precursor and the synthetic route, might help to improve specific activity. However, it has to 
be taken into account that contamination can come at any step of the synthesis process, and 
therefore precautions should be taken at each single step.  
1. Generation of the radioactive precursor in the cyclotron; at this step, the purity of the  
gases, the  material  of  the  target  chamber,  the  windows  and  the  o-rings  (and  the 
procedure followed for their machining and polishing), the size of the target chamber 
and the quality of the irradiated gas have been found to have important effects on the 
introduction of carrier carbon. Beam time and beam current should also be considered. 
The use of high purity gases (with a purification column between the gas source and the 
target), careful cleaning of the target chamber components, the use of metallic o-rings 
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and recovering the target chamber with materials which minimize beam-wall 
interactions lead usually to improvement in AS. Increasing beam time and/or current 
(up to a certain level) offers usually satisfactory results. Preparation protocols have been 
also historically used, e.g. loading and unloading the target before irradiation, 
discarding the first 1-3 irradiations of the day and keeping the target under pressure 
between runs. 
2. Transfer of the irradiated gas to the synthesis box; increasing time decreases specific 
activity, and thus minimizing transfer time leads to higher specific activity values. The 
material of transfer lines (pipes and connections) and the carrier gas (if used) could also 
introduce non radioactive carbon into the reaction environment. This should be 
considered when chosing dimensions (i.e inner diameter; ID) for the transport line: the 
smaller the ID the less the material, but longer empying/delivery time.  Keeping the 
lines pressurized with high purity gases and avoiding carbon-rich materials should 
help, thus, to increase AS. 
3. Synthesis process; at this step, the use of high purity reagents is the most important 
factor. All traps can be activated before synthesis, and reagents should be prepared and 
stored under adequate inert conditions to prevent contamination from the atmosphere. 
Reagents and solvents should be used in minimal amounts, especially in those cases 
where they are supposed to be potential sources of carrier carbon (e.g. LiAlH4 in the 
wet method). Special attention should be paid to the purity of the non radioactive 
precursor, which could be contaminated (ab initio) with the methylated species. The 
synthesis box should be also cleaned and dried thoroughly and kept isolated from 
atmosphere; traces of solvents and direct contact with air contribute to decreased AS.   
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